NHS approves fampridine to help thousands of MS patients walk more freely
NHS England has approved fampridine for routine use in adults with MS and walking impairment rated EDSS 4 to 7.
NHS England has approved fampridine for routine use in adults with MS and walking impairment rated EDSS 4 to 7.